Miromatrix Medical Inc. (MIRO)
NASDAQ: MIRO
· Real-Time Price · USD
3.39
0.02 (0.59%)
At close: Dec 12, 2023, 10:00 PM
Miromatrix Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.18K | 8.52K | 7.98K | 930.36K | 12.39K | 3.95K | 6.77K | 8K | 9.82K | 9.14K | 6.11K |
Cost of Revenue | 125K | 125K | 125K | 125K | 125K | 125K | 125K | 125K | 125K | 125K | 125K |
Gross Profit | -113.82K | -116.48K | -117.02K | 805.36K | -112.61K | -121.05K | -118.23K | -117K | -115.18K | -115.86K | -118.89K |
Operating Income | -6.64M | -6.69M | -8.1M | -7.06M | -7.76M | -8.23M | -7.19M | -5.46M | -5.21M | -3.57M | -2.72M |
Interest Income | 196.68K | 166.16K | 101.98K | 128.07K | 143.56K | 61.08K | 770.00 | 1.12K | 766.00 | 45.00 | 40.00 |
Pretax Income | -6.45M | -6.53M | -7.48M | -6.95M | -7.63M | -8.18M | -7.2M | -5.48M | -5.06M | -3.7M | -434.34K |
Net Income | -6.45M | -6.53M | -7.19M | -6.95M | -7.5M | -8.18M | -7.2M | -5.48M | -5.06M | -3.7M | -434.34K |
Selling & General & Admin | 2.14M | 2.04M | 2.6M | 2.21M | 2.05M | 2.19M | 2.27M | 1.81M | 1.49M | 786.32K | 562.87K |
Research & Development | 3.51M | 3.62M | 4.39M | 4.73M | 4.57M | 4.99M | 4.01M | 3.05M | 3.35M | 2.48M | 1.87M |
Other Expenses | 3.02M | 2.95M | 989.66K | 926.64K | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.52M | 6.57M | 7.98M | 7.87M | 7.64M | 8.11M | 7.07M | 5.34M | 4.98M | 3.33M | 2.45M |
Interest Expense | 15.28K | 8.17K | 10.24K | 12.72K | 15.32K | 8.8K | 10.89K | 12.59K | 15.26K | 310.71K | 337.96K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.65M | 6.7M | 8.11M | 7.99M | 7.77M | 8.24M | 7.2M | 5.47M | 5.1M | 3.45M | 2.57M |
Income Tax Expense | n/a | n/a | -289.93K | 191.39 | -128.23K | 61.08K | 10.89K | n/a | 15.26K | n/a | n/a |
Shares Outstanding (Basic) | 27.31M | 27.25M | 22.51M | 20.91M | 20.9M | 20.62M | 20.48M | 20.33M | 20.15M | 18.96M | 17.77M |
Shares Outstanding (Diluted) | 27.31M | 27.25M | 22.51M | 20.91M | 20.9M | 20.62M | 20.48M | 20.39M | 20.15M | 18.96M | 17.77M |
EPS (Basic) | -0.24 | -0.24 | -0.32 | -0.33 | -0.36 | -0.4 | -0.35 | -0.27 | -0.25 | -0.2 | -0.02 |
EPS (Diluted) | -0.24 | -0.24 | -0.32 | -0.33 | -0.36 | -0.4 | -0.35 | -0.27 | -0.25 | -0.2 | -0.02 |
EBITDA | -6.15M | -6.23M | -7.47M | -6.93M | -7.33M | -7.9M | -6.93M | -5.46M | -5.06M | -3.42M | -2.76M |
EBIT | -6.44M | -6.52M | -7.47M | -7.05M | -7.61M | -8.17M | -7.19M | -5.46M | -5.04M | -3.39M | -96.38K |
Depreciation & Amortization | 288.1K | 289.44K | 629.12K | 128.07K | 424.84K | 334.69K | 263.67K | 74.33K | 34.4K | 29.14K | 30.03K |